131 related articles for article (PubMed ID: 12639922)
21. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12.
Gambotto A; Tüting T; McVey DL; Kovesdi I; Tahara H; Lotze MT; Robbins PD
Cancer Gene Ther; 1999; 6(1):45-53. PubMed ID: 10078963
[TBL] [Abstract][Full Text] [Related]
22. Viral mediated gene therapy for the management of metastatic thyroid carcinoma.
DeGroot LJ; Zhang R
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Sep; 4(3):235-44. PubMed ID: 15379725
[TBL] [Abstract][Full Text] [Related]
23. An adenoviral vector expressing functional heterogeneous proteins herpes simplex viral thymidine kinase and human interleukin-2 has enhanced in vivo antitumor activity against medullary thyroid carcinoma.
Zhang R; DeGroot LJ
Endocr Relat Cancer; 2001 Dec; 8(4):315-25. PubMed ID: 11733228
[TBL] [Abstract][Full Text] [Related]
24. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
[TBL] [Abstract][Full Text] [Related]
25. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer.
Pützer BM; Bramson JL; Addison CL; Hitt M; Siegel PM; Muller WJ; Graham FL
Hum Gene Ther; 1998 Mar; 9(5):707-18. PubMed ID: 9551618
[TBL] [Abstract][Full Text] [Related]
26. Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter.
Takeda T; Inaba H; Yamazaki M; Kyo S; Miyamoto T; Suzuki S; Ehara T; Kakizawa T; Hara M; DeGroot LJ; Hashizume K
J Clin Endocrinol Metab; 2003 Aug; 88(8):3531-8. PubMed ID: 12915632
[TBL] [Abstract][Full Text] [Related]
27. Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas.
Rodriguez-Madoz JR; Zabala M; Alfaro M; Prieto J; Kramer MG; Smerdou C
Hum Gene Ther; 2014 Feb; 25(2):132-43. PubMed ID: 24219025
[TBL] [Abstract][Full Text] [Related]
28. Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer.
Barzon L; Bonaguro R; Castagliuolo I; Chilosi M; Gnatta E; Parolin C; Boscaro M; Palù G
J Clin Endocrinol Metab; 2002 Nov; 87(11):5304-11. PubMed ID: 12414907
[TBL] [Abstract][Full Text] [Related]
29. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.
Addison CL; Bramson JL; Hitt MM; Muller WJ; Gauldie J; Graham FL
Gene Ther; 1998 Oct; 5(10):1400-9. PubMed ID: 9930346
[TBL] [Abstract][Full Text] [Related]
30. Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells.
Geutskens SB; van der Eb MM; Plomp AC; Jonges LE; Cramer SJ; Ensink NG; Kuppen PJ; Hoeben RC
Gene Ther; 2000 Aug; 7(16):1410-6. PubMed ID: 10981668
[TBL] [Abstract][Full Text] [Related]
31. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
[TBL] [Abstract][Full Text] [Related]
32. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
Mitrofanova E; Unfer R; Vahanian N; Link C
Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
[TBL] [Abstract][Full Text] [Related]
33. Virus-mediated oncolysis of thyroid cancer by a replication-selective adenovirus driven by a thyroglobulin promoter-enhancer region.
Kesmodel S; Prabakaran I; Canter R; Menon C; Molnar-Kimber K; Fraker D
J Clin Endocrinol Metab; 2005 Jun; 90(6):3440-8. PubMed ID: 15797967
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
[TBL] [Abstract][Full Text] [Related]
35. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer.
Chen L; Chen D; Block E; O'Donnell M; Kufe DW; Clinton SK
J Immunol; 1997 Jul; 159(1):351-9. PubMed ID: 9200473
[TBL] [Abstract][Full Text] [Related]
36. Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene.
Haiping Z; Takayama K; Uchino J; Harada A; Adachi Y; Kura S; Caicun Z; Tsuzuki T; Nakanishi Y
Cancer Gene Ther; 2006 Sep; 13(9):864-72. PubMed ID: 16710346
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver.
Sung MW; Chen SH; Thung SN; Zhang DY; Huang TG; Mandeli JP; Woo SL
Hum Gene Ther; 2002 Apr; 13(6):731-43. PubMed ID: 11936972
[TBL] [Abstract][Full Text] [Related]
38. Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.
Satoh T; Saika T; Ebara S; Kusaka N; Timme TL; Yang G; Wang J; Mouraviev V; Cao G; Fattah el MA; Thompson TC
Cancer Res; 2003 Nov; 63(22):7853-60. PubMed ID: 14633713
[TBL] [Abstract][Full Text] [Related]
39. Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.
Chang CJ; Chen YH; Huang KW; Cheng HW; Chan SF; Tai KF; Hwang LH
Hepatology; 2007 Mar; 45(3):746-54. PubMed ID: 17326190
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.
Tanaka F; Hashimoto W; Robbins PD; Lotze MT; Tahara H
Gene Ther; 2002 Nov; 9(21):1480-6. PubMed ID: 12378411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
